Roivant Sciences Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 29,825 shares at $8.06 ($248K) on 2019-05-22, disclosed to the SEC on 2019-05-23.
Scheduled purchase ($248k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.52 | 9,995 | $85K | 34.3% |
| 2 | $8.52 | 9,995 | $85K | 34.3% |
| 3 | $8.06 | 5,033 | $41K | 16.3% |
| 4 | $7.76 | 4,802 | $37K | 15.0% |
| Total | $8.32 avg | 29,825 | $248K | 100% |
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |